Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New scan may help men with prostate cancer when standard tests fail

NCT ID NCT07569926

First seen May 08, 2026 · Last updated May 13, 2026 · Updated 2 times

Summary

This study looks at whether a special PET scan using fluciclovine can help doctors decide on treatment for men whose prostate cancer has returned after initial therapy. It is for men whose standard PSMA PET scan was negative or unclear. The goal is to see if this additional scan changes the treatment plan. About 142 men will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Emory University

    Atlanta, Georgia, 30322, United States

    Contact

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

    Contact

  • Oregon Health & Science University

    Portland, Oregon, 97239, United States

    Contact

  • Washington University

    St Louis, Missouri, 63110, United States

    Contact

Conditions

Explore the condition pages connected to this study.